Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation

Therapeutic Drug Monitoring

Volumn 35, Issue 1, 2013, Pages 96-100

  Tempestilli, Massimo ^a   Di Stasio, Enrico ^b   Basile, Maria Rosaria ^a   Elisei, Federica ^a   Antonini, Mario ^c   Ettorre, Giuseppe Maria ^d   Iappelli, Massimo ^d   Pucillo, Leopoldo Paolo ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c National Institute for Infectious Disease L Spallanzani   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

ACMIA; assay interference; LC MS MS; tacrolimus; therapeutic drug monitoring

Indexed keywords

ALBUMIN; TACROLIMUS;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CALIBRATOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; TANDEM MASS SPECTROMETRY;

ADULT; AGED; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SERUM ALBUMIN; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84872843503     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318279dfd2     Document Type: Article

References (23)

1. Venkataramana R, Shaw LM, Sarkozi L, et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol. 2000;141:542-551.
2. Undre NA, Stevenson P, Schäfer A. Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc. 1999;31:21-28.
3. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem. 2001;34:9-16.
4. Schwartz M, Holst B, Facklam D, et al. FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 dose optimization. Transplant Proc. 1995;27:1107-1108.
5. Taylor PJ, Tai CH, Franklin ME, et al. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs. Clin Biochem. 2011;44:14-20.
6. Taylor PJ, Franklin ME, Tai CH, et al. Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test? J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883-884:108-112.
7. Ju MK, Chang HK, Kim HJ, et al. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay? Transplant Proc. 2008; 40:3673-3678.
8. Hermida J, Tutor JC. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Ther Drug Monit. 2009;31:269-272.
9. D'Alessandro M, Mariani P, Mennini G, et al. Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient. Clin Chim Acta. 2011;412:245-248.
10. Tempestilli M, Comandini UV, Vennarecci G, et al. Whole blood levels evaluation measuring tacrolimus by ACMIA method on washed erythrocytes in a liver transplant recipient with circulating heterophilic antibodies. Clin Chim Acta. 2011;412:1480-1481.
11. Brown NW, Gonde CE, Adams JE, et al. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Clin Chem. 2005;51:586-592.
12. Doki K, Homma M, Hori T, et al. Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values. J Pharm Pharmacol. 2010;62:1185-1188.
13. Kuzuya T, Ogura Y, Motegi Y, et al. Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay. Ther Drug Monit. 2002;24:507-511.
14. Joo DJ, Jung I, Kim MS, et al. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. Transplant Proc. 2010;42:4137-4140.
15. Center for Drug Evaluation and Research of the U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry Bioanalytical Method Validation [FDA]; May 2001. Available at: http://www.fda.gov/cder/guidance/4252fnl.htm. Accessed June 2008.
16. Analytical Services International, Ltd. International proficiency testing scheme for tacrolimus. Available at: http://www.bioanalytics.co.uk/html/ tacrolimus-scheme.html/. Accessed November 2007.
17. Alak AM. Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. Ther Drug Monit. 1997;19:338-351.
18. Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31:139-152.
19. Griffey MA, Hock KG, Kilgore DC, et al. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer. Clin Chim Acta. 2007;384:48-51.
20. Zahir H, McCaughan G, Gleeson M, et al. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. Transplant Proc. 2010;42:4137-4140.
21. Wallemacq PE, Verbeeck RK. Comparative clinical pharmacokinetics of tacro limus in paediatric and adult patients. Clin Pharmacokinet. 2001;40:283-295.
22. Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet. 2007;22:328-335.
23. Murthy JN, Davis DL, Yatscoff RW, et al. Tacrolimus metabolite cross-reactivity in different tacrolimus assays. Clin Biochem. 1998;31: 613-617.